Charles River Laboratories (CRL)

Pretax margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	575,538	611,925	621,652	638,181	616,605	534,773	534,342	517,600	472,855	482,890	496,927	454,618	446,112	380,085	317,004	291,698	302,042	271,156	271,434	284,168
Revenue (ttm)	US$ in thousands	4,097,200	4,325,190	4,303,632	4,238,180	4,106,274	3,792,022	3,683,743	3,605,712	3,459,843	3,333,185	3,172,755	2,930,880	2,859,828	2,759,976	2,697,739	2,671,095	2,595,709	2,506,101	2,411,563	2,341,443
Pretax margin		14.05%	14.15%	14.44%	15.06%	15.02%	14.10%	14.51%	14.36%	13.67%	14.49%	15.66%	15.51%	15.60%	13.77%	11.75%	10.92%	11.64%	10.82%	11.26%	12.14%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $575,538K ÷ $4,097,200K
= 14.05%

The pretax margin of Charles River Laboratories has shown some fluctuations over the past five years. The pretax margin ranged from a low of 10.82% in March 2019 to a high of 15.66% in June 2021. Overall, the trend indicates that the company has generally maintained a healthy pretax margin, demonstrating its ability to efficiently generate profits before accounting for taxes. In recent quarters, the pretax margin has been in the range of 14% to 15%, suggesting consistent profitability. It is important to monitor this metric going forward to ensure continued financial health and efficiency in the company's operations.